ASP Isotopes Valuation
Is ASPI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ASPI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ASPI's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ASPI's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ASPI?
Key metric: As ASPI barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is ASPI's PB Ratio? | |
|---|---|
| PB Ratio | 15.4x |
| Book | US$38.70m |
| Market Cap | US$595.39m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 172.3x |
| Enterprise Value/EBITDA | -26.2x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does ASPI's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.7x | ||
ASPN Aspen Aerogels | 2.3x | 54.4% | US$1.2b |
ARQ Arq | 1.5x | 66.1% | US$330.4m |
FTK Flotek Industries | 2.2x | 34.5% | US$241.4m |
RYAM Rayonier Advanced Materials | 0.8x | 163.8% | US$586.0m |
ASPI ASP Isotopes | 15.4x | 75.6% | US$595.4m |
Price-To-Book vs Peers: ASPI is expensive based on its Price-To-Book Ratio (15.4x) compared to the peer average (1.7x).
Price to Book Ratio vs Industry
How does ASPI's PB Ratio compare vs other companies in the US Chemicals Industry?
Price-To-Book vs Industry: ASPI is expensive based on its Price-To-Book Ratio (15.4x) compared to the US Chemicals industry average (1.6x).
Price to Book Ratio vs Fair Ratio
What is ASPI's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 15.4x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate ASPI's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$8.34 | US$6.50 -22.1% | 30.8% | US$8.50 | US$4.50 | n/a | 2 |
| Nov ’25 | US$7.79 | US$6.50 -16.6% | 30.8% | US$8.50 | US$4.50 | n/a | 2 |
| May ’25 | US$3.16 | US$4.25 +34.5% | 29.4% | US$5.50 | US$3.00 | n/a | 2 |
| Apr ’25 | US$4.01 | US$4.13 +2.9% | 27.3% | US$5.25 | US$3.00 | n/a | 2 |
| Mar ’25 | US$3.84 | US$4.13 +7.4% | 27.3% | US$5.25 | US$3.00 | n/a | 2 |
| Feb ’25 | US$2.82 | US$3.13 +10.8% | 4.0% | US$3.25 | US$3.00 | n/a | 2 |
| Jan ’25 | US$1.79 | US$3.13 +74.6% | 4.0% | US$3.25 | US$3.00 | n/a | 2 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Trinseo
US$125.7m
Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.
TSE
US$3.55
7D
2.6%
1Y
-45.6%
Ecora Resources
UK£162.5m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
ECRA.F
UK£0.82
7D
-4.5%
1Y
-28.7%
Allied Gold
CA$1.1b
Explores for and produces mineral deposits in Africa.
AAUC.F
CA$2.47
7D
16.0%
1Y
-18.0%